Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) EBT Margin: 2018-2025

Historic EBT Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -501.92%.

  • Bicycle Therapeutics' EBT Margin rose 152536.00% to -501.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 4,509.57%, marking a year-over-year increase of 735612.00%. This contributed to the annual value of -14,967.50% for FY2024, which is 1151505.00% down from last year.
  • Latest data reveals that Bicycle Therapeutics reported EBT Margin of -501.92% as of Q3 2025, which was up 81.49% from -2,711.75% recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' EBT Margin peaked at 321.52% during Q4 2023, and registered a low of -2,711.75% during Q2 2025.
  • Over the past 3 years, Bicycle Therapeutics' median EBT Margin value was -501.92% (recorded in 2025), while the average stood at -737.03%.
  • Per our database at Business Quant, Bicycle Therapeutics' EBT Margin surged by 209,503bps in 2022 and then slumped by 228,768bps in 2025.
  • Bicycle Therapeutics' EBT Margin (Quarterly) stood at -2,481.12% in 2021, then spiked by 209,503bps to -386.10% in 2022, then soared by 70,761bps to 321.52% in 2023, then tumbled by 12,805bps to 193.47% in 2024, then surged by 152,536bps to -501.92% in 2025.
  • Its EBT Margin stands at -501.92% for Q3 2025, versus -2,711.75% for Q2 2025 and -619.84% for Q1 2025.